ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD -1.85% Market Closed
Market Cap: 107.2m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

ImpediMed Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ImpediMed Ltd
Net Income (Common) Peer Comparison

Comparables:
R
RSH
C
CYC
COH
OIL
EMV

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Net Income (Common)
-AU$19.8m
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
-10%
R
Respiri Ltd
ASX:RSH
Net Income (Common)
-AU$7.1m
CAGR 3-Years
14%
CAGR 5-Years
3%
CAGR 10-Years
4%
C
Cyclopharm Ltd
ASX:CYC
Net Income (Common)
-AU$9.3m
CAGR 3-Years
-29%
CAGR 5-Years
-31%
CAGR 10-Years
-1%
Cochlear Ltd
ASX:COH
Net Income (Common)
AU$356.8m
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
14%
Optiscan Imaging Ltd
ASX:OIL
Net Income (Common)
-AU$6.1m
CAGR 3-Years
-42%
CAGR 5-Years
-21%
CAGR 10-Years
-16%
EMvision Medical Devices Ltd
ASX:EMV
Net Income (Common)
-AU$2.7m
CAGR 3-Years
31%
CAGR 5-Years
2%
CAGR 10-Years
N/A

See Also

What is ImpediMed Ltd's Net Income (Common)?
Net Income (Common)
-19.8m AUD

Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Net Income (Common) amounts to -19.8m AUD.

What is ImpediMed Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-10%

Over the last year, the Net Income (Common) growth was 4%. The average annual Net Income (Common) growth rates for ImpediMed Ltd have been 1% over the past three years , 4% over the past five years , and -10% over the past ten years .

Back to Top